Bulltick Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Bulltick Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Buy	17,190 +852	+5%	+$14.1K	0.06%	112
2026 Q1	$303K	Buy	16,338 +4,941	+43%	+$86.7K	0.07%	113
2025 Q4	$178K	Hold	11,397	–	–	0.04%	125
2025 Q3	$167K	Buy	11,397 +1,143	+11%	+$17K	0.04%	105
2025 Q2	$159K	Buy	+10,254	New	+$152K	0.04%	116

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bulltick Wealth Management's TAK Position: Q2 2026 in Review

Bulltick Wealth Management increased its Takeda Pharmaceutical (TAK) stake by 5.2% in Q2 2026, buying an estimated $14.1K and bringing the position to 17,190 shares worth $281K. The position accounts for 0.06% of the portfolio, ranked #112.

Bulltick Wealth Management first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. The position peaked at $303K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Bulltick Wealth Management held 17,190 shares of Takeda Pharmaceutical worth $281K as of Q2 2026.
Bulltick Wealth Management bought 852 Takeda Pharmaceutical shares in Q2 2026, an estimated $14.1K.
Takeda Pharmaceutical made up 0.06% of Bulltick Wealth Management's portfolio in Q2 2026, its #112 holding.
Bulltick Wealth Management first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
Bulltick Wealth Management's Takeda Pharmaceutical position peaked at $303K in Q1 2026.
379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Bulltick Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.